| Product Code: ETC9954755 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Small Molecule Drug Discovery Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 United Kingdom (UK) Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.6 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume Share, By Process/Phase, 2021 & 2031F |
4 United Kingdom (UK) Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development by pharmaceutical companies |
4.2.2 Technological advancements in drug discovery processes |
4.2.3 Growing prevalence of chronic diseases driving the demand for new drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High costs associated with drug discovery and development |
4.3.3 Limited success rates in translating drug candidates into marketable products |
5 United Kingdom (UK) Small Molecule Drug Discovery Market Trends |
6 United Kingdom (UK) Small Molecule Drug Discovery Market, By Types |
6.1 United Kingdom (UK) Small Molecule Drug Discovery Market, By Therapeutic Area |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Therapeutic Area, 2021- 2031F |
6.1.3 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.1.5 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.6 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.1.7 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.1.8 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.2 United Kingdom (UK) Small Molecule Drug Discovery Market, By Process/Phase |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Target ID/Validation, 2021- 2031F |
6.2.3 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Hit Generation and Selection, 2021- 2031F |
6.2.4 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Lead Identification, 2021- 2031F |
6.2.5 United Kingdom (UK) Small Molecule Drug Discovery Market Revenues & Volume, By Lead Optimization, 2021- 2031F |
7 United Kingdom (UK) Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Small Molecule Drug Discovery Market Export to Major Countries |
7.2 United Kingdom (UK) Small Molecule Drug Discovery Market Imports from Major Countries |
8 United Kingdom (UK) Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Average time from target identification to lead optimization |
8.2 Number of patents filed for new drug candidates |
8.3 Percentage of drug candidates progressing from preclinical to clinical stages |
9 United Kingdom (UK) Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 United Kingdom (UK) Small Molecule Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.2 United Kingdom (UK) Small Molecule Drug Discovery Market Opportunity Assessment, By Process/Phase, 2021 & 2031F |
10 United Kingdom (UK) Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 United Kingdom (UK) Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here